Literature DB >> 34176923

Is one vaccine dose enough if you've had COVID? What the science says.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Immunology; Infection; Public health; SARS-CoV-2; Virology

Mesh：

Substances：

Year:  2021        PMID： 34176923     DOI： 10.1038/d41586-021-01609-4

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.

Authors:  Alessio Mazzoni; Nicoletta Di Lauria; Laura Maggi; Lorenzo Salvati; Anna Vanni; Manuela Capone; Giulia Lamacchia; Elisabetta Mantengoli; Michele Spinicci; Lorenzo Zammarchi; Seble Tekle Kiros; Arianna Rocca; Filippo Lagi; Maria Grazia Colao; Paola Parronchi; Cristina Scaletti; Lucia Turco; Francesco Liotta; Gian Maria Rossolini; Lorenzo Cosmi; Alessandro Bartoloni; Francesco Annunziato
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

2.  Microbiota regulate social behaviour via stress response neurons in the brain.

Authors:  Wei-Li Wu; Mark D Adame; Chia-Wei Liou; Jacob T Barlow; Tzu-Ting Lai; Gil Sharon; Catherine E Schretter; Brittany D Needham; Madelyn I Wang; Weiyi Tang; James Ousey; Yuan-Yuan Lin; Tzu-Hsuan Yao; Reem Abdel-Haq; Keith Beadle; Viviana Gradinaru; Rustem F Ismagilov; Sarkis K Mazmanian
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

3.  Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.

Authors:  Mitnala Sasikala; Jaggaiahgari Shashidhar; Gujjarlapudi Deepika; Vishnubhotla Ravikanth; Vemula Venkata Krishna; Yelamanchili Sadhana; Kottapalli Pragathi; Duvvur Nageshwar Reddy
Journal:  Int J Infect Dis       Date:  2021-05-19       Impact factor: 3.623

4.  Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.

Authors:  Rishi R Goel; Sokratis A Apostolidis; Mark M Painter; Divij Mathew; Ajinkya Pattekar; Oliva Kuthuru; Sigrid Gouma; Philip Hicks; Wenzhao Meng; Aaron M Rosenfeld; Sarah Dysinger; Kendall A Lundgreen; Leticia Kuri-Cervantes; Sharon Adamski; Amanda Hicks; Scott Korte; Derek A Oldridge; Amy E Baxter; Josephine R Giles; Madison E Weirick; Christopher M McAllister; Jeanette Dougherty; Sherea Long; Kurt D'Andrea; Jacob T Hamilton; Michael R Betts; Eline T Luning Prak; Paul Bates; Scott E Hensley; Allison R Greenplate; E John Wherry
Journal:  Sci Immunol       Date:  2021-04-15

5.  SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.

Authors:  Matthew Frieman; Anthony D Harris; Ramin Sedaghat Herati; Florian Krammer; Alberto Mantovani; Maria Rescigno; Mohammad M Sajadi; Viviana Simon
Journal:  EBioMedicine       Date:  2021-05-26       Impact factor: 8.143

6.  Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.

Authors:  Jonathan G Braun; Susan Cheng; Kimia Sobhani; Joseph E Ebinger; Justyna Fert-Bober; Ignat Printsev; Min Wu; Nancy Sun; John C Prostko; Edwin C Frias; James L Stewart; Jennifer E Van Eyk
Journal:  Nat Med       Date:  2021-04-01       Impact factor: 53.440

7.  Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.

Authors:  Florian Krammer; Komal Srivastava; Hala Alshammary; Angela A Amoako; Mahmoud H Awawda; Katherine F Beach; Maria C Bermúdez-González; Dominika A Bielak; Juan M Carreño; Rachel L Chernet; Lily Q Eaker; Emily D Ferreri; Daniel L Floda; Charles R Gleason; Joshua Z Hamburger; Kaijun Jiang; Giulio Kleiner; Denise Jurczyszak; Julia C Matthews; Wanni A Mendez; Ismail Nabeel; Lubbertus C F Mulder; Ariel J Raskin; Kayla T Russo; Ashley-Beathrese T Salimbangon; Miti Saksena; Amber S Shin; Gagandeep Singh; Levy A Sominsky; Daniel Stadlbauer; Ania Wajnberg; Viviana Simon
Journal:  N Engl J Med       Date:  2021-03-10       Impact factor: 91.245
  7 in total
  14 in total

1.  Perplexity as a provocation: revisiting the role of metaphor as a 'place holder' for the potential of COVID-19 antibodies.

Authors:  Marsha Rosengarten
Journal:  Med Humanit       Date:  2022-05-30

2.  Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.

Authors:  Lucy L Li; Chunlei Zheng; Jennifer La; Nhan V Do; Paul A Monach; Judith M Strymish; Nathanael R Fillmore; Westyn Branch-Elliman
Journal:  Vaccine       Date:  2022-01-19       Impact factor: 3.641

3.  Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.

Authors:  Rossana Elena Chahla; Rodrigo Hernán Tomas-Grau; Silvia Inés Cazorla; Diego Ploper; Esteban Vera Pingitore; Mónica Aguilar López; Patricia Aznar; María Elena Alcorta; Eva María Del Mar Vélez; Agustín Stagnetto; César Luís Ávila; Carolina Maldonado-Galdeano; Sergio Benjamín Socias; Dar Heinze; Silvia Adriana Navarro; Conrado Juan Llapur; Dardo Costa; Isolina Flores; Alexis Edelstein; Shreyas Kowdle; Claudia Perandones; Benhur Lee; Gabriela Apfelbaum; Raúl Mostoslavsky; Gustavo Mostoslavsky; Gabriela Perdigón; Rosana Nieves Chehín
Journal:  Lancet Reg Health Am       Date:  2021-11-20

4.  Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.

Authors:  Rachael K Raw; Jon Rees; Clive A Kelly; Caroline Wroe; David R Chadwick
Journal:  Vaccine       Date:  2021-12-04       Impact factor: 3.641

Review 5.  COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.

Authors:  Nicoletta Luxi; Alexia Giovanazzi; Annalisa Capuano; Salvatore Crisafulli; Paola Maria Cutroneo; Maria Pia Fantini; Carmen Ferrajolo; Ugo Moretti; Elisabetta Poluzzi; Emanuel Raschi; Claudia Ravaldi; Chiara Reno; Marco Tuccori; Alfredo Vannacci; Giovanna Zanoni; Gianluca Trifirò
Journal:  Drug Saf       Date:  2021-11-05       Impact factor: 5.606

6.  Testing fractional doses of COVID-19 vaccines.

Authors:  Witold Więcek; Amrita Ahuja; Esha Chaudhuri; Michael Kremer; Alexandre Simoes Gomes; Christopher M Snyder; Alex Tabarrok; Brandon Joel Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 11.205

7.  mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron.

Authors:  Hye Kyung Lee; Ludwig Knabl; Juan I Moliva; Ludwig Knabl; Anne P Werner; Seyhan Boyoglu-Barnum; Sebastian Kapferer; Birgit Pateter; Mary Walter; Nancy J Sullivan; Priscilla A Furth; Lothar Hennighausen
Journal:  Cell Rep       Date:  2022-03-25       Impact factor: 9.995

8.  Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.

Authors:  Thiago Cerqueira-Silva; Jason R Andrews; Viviane S Boaventura; Otavio T Ranzani; Vinicius de Araújo Oliveira; Enny S Paixão; Juracy Bertoldo Júnior; Tales Mota Machado; Matt D T Hitchings; Murilo Dorion; Margaret L Lind; Gerson O Penna; Derek A T Cummings; Natalie E Dean; Guilherme Loureiro Werneck; Neil Pearce; Mauricio L Barreto; Albert I Ko; Julio Croda; Manoel Barral-Netto
Journal:  Lancet Infect Dis       Date:  2022-04-01       Impact factor: 71.421

9.  Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.

Authors:  Lea Nevo; Adva Cahen-Peretz; Olesya Vorontsov; Rachelli Frenkel; Maor Kabessa; Sarah M Cohen; Adar Hamrani; Esther Oiknine-Djian; Michal Lipschuetz; Debra Goldman-Wohl; Asnat Walfisch; Michal Kovo; Michal Neeman; Simcha Yagel; Dana G Wolf; Ofer Beharier
Journal:  Am J Obstet Gynecol       Date:  2022-04-14       Impact factor: 10.693

10.  Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.

Authors:  Bilal Mahmood Beg; Tariq Hussain; Mehmood Ahmad; Sadaf Areej; Arfa Majeed; Muhammad Adil Rasheed; Muhammad Moin Ahmad; Qurat-Ul-Ain Shoaib; Sadaf Aroosa
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.